Global /Romania /Healthcare /Drug Manufacturers - General /BIO

Biofarm S.A.

BIO

• BVB: BIO • Delayed

1.24RON -1.6%

0.2740 USD

As of 5 June 2026, Biofarm S.A. has a market cap of $269.62M USD, ranking #19249 globally and #25 in Romania. It ranks #1733 in the Healthcare sector, and #633 in the Drug Manufacturers - General industry.

Global Rank

19249

Country Rank

Sector Rank

1733

Industry Rank

633

Key Stats

Market Cap

$269.62MUSD

1.22B RON

Enterprise Value

$232.59MUSD

1.05B RON

Revenue (TTM)

$70.47MUSD

319.33M RON

EBITDA (TTM)

$25.33MUSD

114.64M RON

Net Income (TTM)

$22.21MUSD

100.63M RON

EBITDA Margin

36%

Profit Margin

32%

PE Ratio

13.5

PS Ratio

3.8

PB Ratio

2.2

EV/EBITDA

9.2

Company Profile

Country (HQ)

Romania

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Catalin Vicol open_in_new

Employees

369

Founded

1921

Website

biofarm.ro open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.6%	0.8%	-3.5%	11%	56%	53%	83%	86%	94%

News

Markets

Exchange	Ticker	Price	Quotes
Bucharest Stock Exchange (BVB) MIC: XBSE PRIMARY	BIO Biofarm SA ISIN: ROBIOFACNOR9 Shares Out.: Shares Outstanding: 985.367M¹ Shares Float: 985.367M² TV: TradingView: BVB: BIO SA: Stock Analysis: BVB: BIO YF: Yahoo Finance: BIO.RO GF: Google Finance: BVB: BIO BA: Barron's: BIO MS: Morningstar: XBSE: BIO	1.24 RON	TV: TradingView: BVB: BIO SA: Stock Analysis: BVB: BIO YF: Yahoo Finance: BIO.RO GF: Google Finance: BVB: BIO BA: Barron's: BIO MS: Morningstar: XBSE: BIO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Biofarm S.A.

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, medical devices, and other products. The company also exports its products in Albania, Azerbaijan, Georgia, Jordan, Iraq, Kyrgyzstan, Malta, Republic of Moldova, Serbia, and Hungary. Biofarm S.A. was incorporated in 1921 and is based in Bucharest, Romania.

Similar Companies

Industry: Drug Manufacturers - General (Romania)

Name	Market Cap (USD) diff.	PE	Country
Antibiotice S.A. BVB: ATB	$263.99M 1.2B RON -2.1%	23.1	Romania
S.C. Sintofarm S.A. BVB: SINT	$5.58M 25.29M RON -98%	77.3	Romania

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 282K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 203K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 134K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 120K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 107K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 102K%	20.5	Switzerland

chevron_leftBack